Original articleGeneral thoracicPrognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer
Section snippets
Patients
We included all patients treated at our center, between January 2004 and January 2011, for central airway obstruction caused by lung cancer. Exclusion criteria were endobronchial metastasis, tracheoesophageal fistula from esophageal cancer, and tumors with uncertain malignancies.
We collected data on age, sex, body mass index, and American Society of Anesthesiologists (ASA) score, plus details of preoperative radiography (atelectasis, pneumonia) from each patient. The characteristics of the
Population
The study included 204 patients, of which 153 were men (74.8%). The average age was 64.4 years. The characteristics of the patients and types of cancer are reported in Table 1.
The ASA score was 3 or 4 for 79.7% of patients, and ASA 2 for only 20.3%. Squamous cell carcinoma strongly predominated over other histologic types, followed by adenocarcinoma (19.6%). Patients were treated for locally advanced (stage IIIA or IIIB in 61%) or metastatic disease (39%). The sites of the lesions are described
Comment
Intervention was considered effective (according to endoscopic criteria) in the vast majority of cases, as has been reported by other teams 15, 18. A complication was noted in 10.3% of our cases. The mortality rate in the first 48 hours was only 1.9%. Of these 4 patients, 3 were ASA score 4, 3 had metastatic cancer, and 3 had been treated for acute respiratory distress. We observed more complications than when a single thermal method was used 7, 19, but our rate of complications is similar to
References (32)
- et al.
Clinical outcomes with airway stents for proximal versus distal malignant tracheobronchial obstructions
J Vasc Interv Radiol
(2004) - et al.
Pattern of failure and survival in endobronchial LASER resection. A matched pair study
Chest
(1994) - et al.
Nd:YAG laser bronchoscopy. A five-year experience with 1,396 applications in 1,000 patients
Chest
(1988) - et al.
Endobronchial palliation using Nd:YAG laser is associated with improved survival when combined with multimodal adjuvant treatments
J Thoracic Oncol
(2007) - et al.
Nd-YAG laser vs bronchoscopic electrocautery for palliation of symptomatic airway obstruction: a cost-effectiveness study
Chest
(1999) - et al.
Endobronchial argon plasma coagulation for treatment of hemoptysis and neoplastic airway obstruction
Chest
(2001) - et al.
Photodynamic laser therapy for lesions in the airway
Ann Thorac Surg
(2010) - et al.
Endoscopic treatment of malignant airway obstructions in 2,008 patients
Chest
(1996) - et al.
Silicone stents in the management of inoperable tracheobronchial stenoses. Indications and limitations
Chest
(1993) - et al.
Airway stents
Ann Thorac Surg
(2008)
Neoplastic severe central airways obstruction, interventional bronchoscopy: a decision-making analysis
J Thorac Cardiovasc Surg
Safety and efficacy of thoracic external beam radiotherapy after airway stenting in malignant airway obstruction
Intl J Radiat Oncol Biol Phys
Prospective risk-adjusted morbidity and mortality outcome analysis after therapeutic bronchoscopic procedures: results of a multi-institutional outcomes database
Chest
A two-year experience with the neodymium-YAG laser in endobronchial obstruction
Chest
Timely airway stenting improves survival in patients with malignant central airway obstruction
Ann Thorac Surg
Self-expandable metallic airway stent insertion employing flexible bronchoscopy: preliminary results
Chest
Cited by (32)
Non-infectious respiratory emergencies in patients with cancer
2023, Revue des Maladies RespiratoiresBronchoscopic management of malignant central airway obstructions
2023, Revue des Maladies RespiratoiresL'endoscopie interventionnelle (désobstruction et prothèse)
2022, Revue des Maladies Respiratoires ActualitesAirway stenting: State of the art
2022, Revue des Maladies RespiratoiresIntegrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE)
2020, Lung CancerCitation Excerpt :Second, we should consider which is the real advantage in survival following interventional bronchoscopy in stage IIIB NSCLC. Previous studies have analyzed the outcome of NSCLC patients undergoing interventional bronchoscopy in a heterogeneous population, mixing up locally advanced NSCLC and stage IV, without a reliable control group, providing inconclusive results (16–24). Some data suggest that there is no difference in survival between patients free from CAO receiving chemotherapy, compared to those symptomatics who underwent successful interventional bronchoscopy followed by adjuvant chemotherapy (16).
Clinical case no. 5: Interventional bronchoscopy for the management of symptomatic proximal malignant stenosis. For which patients? What are the alternatives?
2016, Revue des Maladies Respiratoires Actualites